Interstitial Lung Disease
Conditions
Interventions
None listed
Sponsors
Institute of Science Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 20 years or older Outpatients diagnosed with fibrotic interstitial lung disease and followed at the Department of Respiratory Medicine, Institute of Science Tokyo Hospital Patients judged by the attending physician to be at potential risk of future disease progression Patients who do not meet the criteria for initiation of home oxygen therapy at the time of enrollment Patients who have provided written informed consent to participate in this study
Exclusion criteria
Exclusion criteria: Patients diagnosed with pulmonary hypertension Patients whose SpO2 falls below 85% during the 6-minute walk test at the time of enrollment Patients judged by the attending physician to have a poor prognosis that would preclude completion of the study period Patients who have difficulty attending regular outpatient visits Patients deemed unsuitable for participation in the study by the principal investigator or sub-investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity of continuous home SpO2 monitoring for detecting SpO2 <85%, compared with the 6-minute walk test. | — |
Secondary
| Measure | Time frame |
|---|---|
| To examine the association between hypoxemia detected by home SpO2 monitoring and pulmonary function decline or echocardiographic findings suggestive of pulmonary hypertension. To compare the detection sensitivity of SpO2 <90% between home SpO2 monitoring and the 6-minute walk test. To assess correlations between home SpO2 monitoring data and patient activity or clinical parameters. | — |
Countries
Japan
Contacts
Public ContactTomoya Tateishi
Institute of Science Tokyo Hospital Department of Respiratory Medicine
Outcome results
None listed